SOMERSET, N.J., July 15, 2008 (PRIME NEWSWIRE) -- inVentiv Health, Inc. (Nasdaq:VTIV) today announced that it will release its second quarter 2008 results and conduct a conference call on Thursday, August 7, 2008 at 9:00 a.m. Eastern Daylight Time.
Conference Call Details
To listen to the call, please dial 800-358-8448 (Domestic) or 706-902-2979 (International). The conference call also will be webcast live at www.inVentivHealth.com/health/newsroom/webcasts.asp. Please go to the site at least 15 minutes in advance of the call to register, download and install any necessary audio software.
In concert with the call, information regarding inVentiv Health's historical and recent operational and financial performance will be available at www.inVentivHealth.com/health/investorRelations/investorDecks.asp.
An archived webcast will be available at www.inVentivHealth.com/health/newsroom/webcasts.asp, and a replay of the call will be available immediately following the call through August 14, 2008 at 800-642-1687. The conference ID number for the replay is 55382756.
About inVentiv Health
inVentiv Health, Inc. (Nasdaq:VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit www.inVentivHealth.com.
The inVentiv Health, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4942
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.